CClinicalTrials.gg
Status unknownNCT01589354Updated May 2, 2012

Effectiveness of Interscalene Brachial Plexus Block and Intra-articular Injection of Ropivacaine for Post-operative Analgesia in Arthroscopic Shoulder Stabilization Surgery

An interventional study of Interscalene brachial plexus block and Intra-articular Ropivacaine injection in Postoperative Analgesia, sponsored by NHS Grampian. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-05-02.

Sponsored by NHS Grampian · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Apr 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates two anaesthetic techniques namely interscalene brachial plexus block and intra-articular local anaesthetic injection. Both techniques are currently used for providing postoperative pain relief following arthroscopic shoulder stabilisation operation. It will be a randomised controlled trial involving 30 patients in two groups.

02

Conditions studied

  • Postoperative Analgesia

Browse trials for

03

In context

Agnosia

1,190 studies on the registry are indexed under Agnosia; 508 are open to participants now.

This study's planned enrollment of 60 is below the median of 78 across 1,024 interventional studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

NHS Grampian is the lead sponsor of 20 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All adult patients above the age of 18 years undergoing arthroscopic shoulder stabilisation operation

Exclusion criteria

Exclusion Criteria:

  • Patients not meeting inclusion criteria
  • Patients unable to give informed consent
  • Patient refusal to participate in the study
  • Contraindications to Interscalene block
  • Allergy to local anaesthetics
  • Peripheral neuropathy from any cause
  • Patients on opiates for chronic pain
  • Pregnant women
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Interscalene brachial plexus block

    Procedure: Interscalene brachial plexus block · Device: Ultrasound guided technique · Drug: Ropivacaine

  • Experimental
    Intra-articular injection

    Procedure: Intra-articular Ropivacaine injection · Drug: Ropivacaine

Interventions

  • ProcedureInterscalene brachial plexus block

    An interscalene block will be performed pre-operatively using ultrasound guidance and the peripheral nerve stimulator (with the patient awake) using 20 ml of 0.375% Ropivacaine.

  • ProcedureIntra-articular Ropivacaine injection

    The procedure will be done by the surgeon at the end of the operation, with an intra-articular injection of 20 ml 0.75% Ropivacaine through the arthroscopic cannula after closure of the anterior wound

  • DeviceUltrasound guided technique

    The block will be performed under U/S guidance

  • DrugRopivacaine

    20ml of 0.375% Ropivacaine

  • DrugRopivacaine

    20ml of 0.75% Ropivacaine injected by the surgeon at the end of the procedure

06

What researchers measure

Primary outcomes

  1. Mean pain score over the first 24 hours following arthroscopic shoulder stabilisation operation

    Time frame: 24 months

Secondary outcomes

  1. Post-operative analgesic requirements in the first 24 hours after surgery

    Time frame: 24 months

  2. Patient assessment of quality of analgesia and identifying any complications as a result of the two anaesthetic procedures

    Time frame: 24 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01589354
Lead sponsor
NHS Grampian
Responsible party
Amr M Mahdy (Dr, NHS Grampian) — Principal investigator
First posted
May 1, 2012
Start date
May 2012
Primary completion
May 2014 (estimated)
Completion
May 2014 (estimated)
Last update
May 2, 2012

Study contacts

Amr M Mahdy, MD
principal investigator · NHS Grampian

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion